RIBOTECT Trademark

Trademark Overview


On Tuesday, August 6, 2019, a trademark application was filed for RIBOTECT with the United States Patent and Trademark Office. The USPTO has given the RIBOTECT trademark a serial number of 79268012. The federal status of this trademark filing is REGISTERED as of Tuesday, October 13, 2020. This trademark is owned by BioNTech RNA Pharmaceuticals GmbH. The RIBOTECT trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Chemical reagents for medical and veterinary purposes; Medical and pharmaceutical preparations comprising liposomes, lipoplexes, polyplexes, microparticles, nanoparticles, or lipid-based emulsions for the treatment and prevention of cancerous diseases, infectious diseases, autoimmune disorders, genetic defects or metabolic disorders; Medical and pharmaceutical preparations comprising, in particular, liposomes, lipoplexes, polyplexes, microparticles, nanoparticles, or lipid-based emulsions and comprising additional active ingredients, in particular proteins or nucleid acids for the treatment and prevention of cancerous diseases, infectious diseases, autoimmune disorders, genetic defects or metabolic disorders; Carriers and carrier systems, namely, drug delivery agents in the form of powders, tablets, liposomes, lipoplexes, polyplexes, microparticles, nanoparticles, or lipid-based emulsions and capsules that provide controlled release of the active ingredients for pharmaceuticals for use...

Medical and veterinary services in connection with cancer diseases, infectious diseases, autoimmune disorders, genetic defects, and metabolic disorders

Scientific research for medical and veterinary purposes, in particular for treatment of cancer, infectious diseases, autoimmune disorders, genetic defects, and metabolic disorders, using liposomes, lipoplexes, polyplexes, microparticles, nanoparticles, or emulsions
ribotect

General Information


Serial Number79268012
Word MarkRIBOTECT
Filing DateTuesday, August 6, 2019
Status700 - REGISTERED
Status DateTuesday, October 13, 2020
Registration Number6171861
Registration DateTuesday, October 13, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 28, 2020

Trademark Statements


Goods and ServicesChemical reagents for medical and veterinary purposes; Medical and pharmaceutical preparations comprising liposomes, lipoplexes, polyplexes, microparticles, nanoparticles, or lipid-based emulsions for the treatment and prevention of cancerous diseases, infectious diseases, autoimmune disorders, genetic defects or metabolic disorders; Medical and pharmaceutical preparations comprising, in particular, liposomes, lipoplexes, polyplexes, microparticles, nanoparticles, or lipid-based emulsions and comprising additional active ingredients, in particular proteins or nucleid acids for the treatment and prevention of cancerous diseases, infectious diseases, autoimmune disorders, genetic defects or metabolic disorders; Carriers and carrier systems, namely, drug delivery agents in the form of powders, tablets, liposomes, lipoplexes, polyplexes, microparticles, nanoparticles, or lipid-based emulsions and capsules that provide controlled release of the active ingredients for pharmaceuticals for use in the treatment of cancer, infectious diseases, autoimmune disorders, genetic defects, and metabolic disorders
Goods and ServicesMedical and veterinary services in connection with cancer diseases, infectious diseases, autoimmune disorders, genetic defects, and metabolic disorders
Goods and ServicesScientific research for medical and veterinary purposes, in particular for treatment of cancer, infectious diseases, autoimmune disorders, genetic defects, and metabolic disorders, using liposomes, lipoplexes, polyplexes, microparticles, nanoparticles, or emulsions

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 2, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, October 2, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, October 2, 2019
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBioNTech SE
Party Type30 - Original Registrant
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Party NameBioNTech RNA Pharmaceuticals GmbH
Party Type20 - Owner at Publication
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Party NameBioNTech RNA Pharmaceuticals GmbH
Party Type10 - Original Applicant
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Trademark Events


Event DateEvent Description
Wednesday, October 2, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 26, 2019SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, October 8, 2019APPLICATION FILING RECEIPT MAILED
Monday, November 4, 2019ASSIGNED TO EXAMINER
Saturday, November 9, 2019NON-FINAL ACTION WRITTEN
Sunday, November 10, 2019NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, November 30, 2019REFUSAL PROCESSED BY MPU
Saturday, November 30, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, December 20, 2019REFUSAL PROCESSED BY IB
Thursday, May 28, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 28, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, May 28, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 8, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, June 20, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 31, 2020NOTIFICATION PROCESSED BY IB
Wednesday, July 15, 2020NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, July 15, 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, July 28, 2020PUBLISHED FOR OPPOSITION
Tuesday, July 28, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 13, 2020REGISTERED-PRINCIPAL REGISTER
Friday, January 29, 2021FINAL DISPOSITION PROCESSED
Wednesday, January 13, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, November 19, 2021CHANGE OF NAME/ADDRESS REC'D FROM IB
Thursday, May 30, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, May 30, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, May 30, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, May 30, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 30, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, May 30, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Saturday, February 20, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, January 29, 2021FINAL DISPOSITION NOTICE SENT TO IB